MRK vs OPCH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MRK shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
OPCH exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency. However, the stock is trading at a significant premium to its Graham Number ($15.54) and Intrinsic Value ($11.37), suggesting a valuation disconnect based on defensive metrics. While analysts maintain a 'strong_buy' rating with a target of $40.09, this optimism is countered by bearish insider selling and a completely bearish technical trend. The outlook is balanced between strong balance sheet health and an overextended valuation relative to current earnings growth.
Compare Another Pair
Related Comparisons
MRK vs OPCH: Head-to-Head Comparison
This page compares Merck & Co., Inc. (MRK) and Option Care Health, Inc. (OPCH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.